MBRX · Moleculin Biotech, Inc. · Off Exchange
$7.74
-0.19 (-2.40%)
At close · Nov 20
Return incl. dividend (before tax)
Q1 2025 earnings call transcript
Going-concern doubt
— flagged Nov 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Nov 13, 2026
Market Cap
$8.22M
Shares
1.06M
Volume · Nov 20
49.56K
Avg daily vol (24 sessions)
44.57K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-10-12 | 2,406 | 63,082 | 65,488 | 100.0% |
| 2026-10-05 | 4,148 | 62,595 | 66,743 | 100.0% |
| 2026-09-28 | 13,615 | 117,147 | 130,762 | 100.0% |
| 2026-09-21 | 43,169 | 429,709 | 472,878 | 100.0% |
| 2026-09-14 | 4,976 | 57,025 | 62,001 | 100.0% |
| 2026-09-07 | 7,381 | 94,221 | 101,602 | 100.0% |
| 2026-08-31 | 4,894 | 60,913 | 65,807 | 100.0% |
| 2026-08-24 | 6,678 | 94,639 | 101,317 | 100.0% |
| 2026-08-17 | 10,077 | 79,083 | 89,160 | 100.0% |
| 2026-08-10 | 16,959 | 166,588 | 183,547 | 100.0% |
| 2026-08-03 | 36,541 | 408,904 | 445,445 | 100.0% |
| 2026-07-27 | 49,455 | 544,483 | 593,938 | 100.0% |
| 2026-07-20 | 1,019 | 4,827 | 5,846 | 100.0% |
| 2026-07-13 | 2,796 | 12,623 | 15,419 | 100.0% |
| 2026-07-06 | 4,804 | 21,032 | 25,836 | 100.0% |
| 2026-06-29 | 20,723 | 112,885 | 133,608 | 100.0% |
| 2026-06-22 | 28,662 | 267,999 | 296,661 | 100.0% |
| 2026-06-15 | 4,412 | 23,611 | 28,023 | 100.0% |
| 2026-06-08 | 3,085 | 21,454 | 24,539 | 100.0% |
| 2026-06-01 | 6,819 | 37,905 | 44,724 | 100.0% |
| 2026-05-25 | 4,239 | 36,553 | 40,792 | 100.0% |
| 2026-05-18 | 4,114 | 25,304 | 29,418 | 100.0% |
| 2026-05-11 | 9,010 | 46,612 | 55,622 | 100.0% |
| 2026-05-04 | 2,576 | 23,806 | 26,382 | 100.0% |
| 2026-04-27 | 1,128 | 11,510 | 12,638 | 100.0% |
| 2026-04-20 | 1,899 | 21,555 | 23,454 | 100.0% |
| 2026-04-13 | 1,869 | 12,629 | 14,498 | 100.0% |
| 2026-04-06 | 1,090 | 10,549 | 11,639 | 100.0% |
| 2026-03-30 | 447 | 8,869 | 9,316 | 100.0% |
| 2026-03-23 | 2,043 | 16,696 | 18,739 | 100.0% |
| 2026-03-16 | 1,956 | 10,946 | 12,902 | 100.0% |
| 2026-03-09 | 3,266 | 16,539 | 19,805 | 100.0% |
| 2026-03-02 | 1,610 | 12,131 | 13,741 | 100.0% |
| 2026-02-23 | 3,480 | 21,771 | 25,251 | 100.0% |
| 2026-02-16 | 15,733 | 73,011 | 88,744 | 100.0% |
| 2026-02-09 | 1,948 | 3,353 | 5,301 | 100.0% |
| 2026-02-02 | 3,869 | 10,640 | 14,509 | 100.0% |
| 2026-01-26 | 2,110 | 9,007 | 11,117 | 100.0% |
| 2026-01-19 | 3,152 | 14,563 | 17,715 | 100.0% |
| 2026-01-12 | 2,493 | 18,611 | 21,104 | 100.0% |
| 2026-01-05 | 3,094 | 19,297 | 22,391 | 100.0% |
| 2025-12-29 | 1,334 | 11,834 | 13,168 | 100.0% |
| 2025-12-22 | 1,575 | 8,670 | 10,245 | 100.0% |
| 2025-12-15 | 5,277 | 124,372 | 129,649 | 100.0% |
| 2025-12-08 | 9,973 | 77,273 | 87,246 | 100.0% |
| 2025-12-01 | 2,337 | 19,689 | 22,026 | 100.0% |
| 2025-11-24 | 2,800 | 22,705 | 25,505 | 100.0% |
Showing 1–47 of 47 weeks
Key facts
CIK
1659617
CUSIP
60855D507
13F (30d)
32 filings
22 filers
Visit website
Investor relations